Karin Eastham

Karin Eastham

DirectoratVeracyte· In proxies 2023–2025

Karin Eastham sits on 10 public boards.

Boards1

  • VeracyteDirector · 11 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. VeracytePublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +111%
  2. Geron CorporationPublic company
    • Director? – PresentNo stock prices for these years
  3. Nektar TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  4. Personalis, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Genoptix, Inc.Public company · 18 yr
    • Director2008 – Present · 18 yrNo stock prices for these years
  6. Trius Therapeutics, Inc.Public company · 19 yr
    • Director2007 – Present · 19 yrNo stock prices for these years
  7. Amylin Pharmaceuticals, Inc.Public company · 21 yr
    • Director2005 – Present · 21 yrNo stock prices for these years
  8. Tercica, Inc.Public company · 23 yr
    • Director2003 – Present · 23 yrNo stock prices for these years
  9. Illumina, Inc.Public company · 15 yr
    • Director2004 – 2019 · 15 yrNo stock prices for these years
  10. MorphoSys AGPublic company · 5 yr
    • Director2012 – 2017 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?